Knowledge Center
In response to a recent Executive Order, the Treasury Department and IRS issued Notice 2019-45, expanding the list of preventive care benefits covered under a QHDHP.
The New York State Department of Health issued guidance on the use of COVID-19 sick leave, which appears to expand the ability of individuals to access COVID-19 sick leave beyond the scope of the
For quarters beginning on and after January 1, 2020, CMS will require Responsible Reporting Entities (RREs) to include information on prescription drugs in their Section 111 quarterly reporting.
091019 California Relaxes Registration Requirements for Opposite-Sex Domestic Partners
060220 New Jersey Expands Disability and Leave Benefits to Address COVID-19 My Benefit Advisor Compliance
In a bipartisan effort, the U.S. Congress agreed on a spending package to fund the federal government which included important changes to federal laws affecting employer-sponsored group health and
Late on March 18, 2020, President Trump signed into law the Families First Coronavirus Response Act (which included some technical changes since the proposed bill was passed by the House). This
While many states have enacted their own legislation surrounding the coronavirus disease 2019 (COVID-19), the federal government has begun releasing guidance and proposed legislation with respect to
Although the severity and extent of the COVID-19 pandemic has been unprecedented in modern times, there are safeguards built into the structure of the insurance industry that are designed to maintain
Specialty drugs are expensive medications that are used to treat complex, chronic medical conditions. They are often given by injection or infusion and are potential life savers for patients
Our Advisors offer in-depth analysis and are ready to help you successfully navigate employee benefits and health insurance.
Our website uses cookies. Click here to view our privacy policy.